R(+)-Etomoxir (sodium salt)

  Cat. No.:  DC7412   Featured
Chemical Structure
828934-41-4
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
A PPARα agonist and an irreversible CPT-1 inhibitor.
Cas No.: 828934-41-4
Chemical Name: (2R)-2-[6-(4-chlorophenoxy)hexyl]-2-oxiranecarboxylic acid monosodium salt
Synonyms: Etomoxir sodium; B 807-54; B807-54; B-807-54; B 80754; B80754; B-80754;
SMILES: [Na+].O1C[C@@]1(CCCCCCOC1=CC=C(Cl)C=C1)C([O-])=O
Formula: C15H18ClNaO4
M.Wt: 320.7448
Sotrage: 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
Description: (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig.
In Vitro: (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig[1].
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC9602 Balaglitazone Balaglitazone (DRF-2593; NN-2344) is a novel partial agonist of PPAR-γ.
DC7412 R(+)-Etomoxir (sodium salt) A PPARα agonist and an irreversible CPT-1 inhibitor.
DC1034 WY14643 (Pirinixic Acid) WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with ED50 of 1.5 μM.
DC10700 Seladelpar Seladelpar is a selective peroxisome proliferator-activated receptor (SPPAR) -δ receptor agonist.
DC12034 MA-0204 MA-0204 is a potent, selective PPARδ modulator with good pharmacokinetic properties.
DC2079 GW-9662 GW9662 is a selective PPAR antagonist, inhibiting PPARγ, PPARα and PPARδ with IC50 of 3.3 nM, 32 nM and 2 μM, respectively.
DC4233 GW501516 GW501516 is the most selective and potent PPARβ (EC50=1.1nM) agonist that has been demonstrated to be 1,000-fold more selective in comparison to existing subtypes.
DC9904 GW0742 GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
DC2078 GW-7647 GW 7647 is a potent PPARα agonist with 200-fold selectivity over PPARγ and PPARδ.
DC1035 GSK3787 GSK3787 is as a potent and selective antagonist of PPARδ with pIC50 of 6.6.
X